title: Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
authors.forename: Makoto
authors.initials: M
authors.lastname: Ishitobi
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Kosaka
authors.forename: Ken-Ichi
authors.initials: K
authors.lastname: Shukunami
authors.forename: Tetsuhito
authors.initials: T
authors.lastname: Murata
authors.forename: Yuji
authors.initials: Y
authors.lastname: Wada
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination / Q000379:methods*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D015363:Quinolones / Q000008:administration & dosage / Q000627:therapeutic use*; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D018967:Risperidone